FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328049268> ?p ?o ?g. }

• W4328049268 abstract "Metronidazole (MNZ) is administered as first-line antibiotic for Helicobacter pylori eradication therapy; however, increasing resistance to MNZ impaired the efficacy. Increasing the dose of MNZ was recommended to overcome low-level resistance, but it was difficult to determine MNZ resistance level simply based on the rdxA gene mutation. In this study, the rdxA sequences of 511 clinical H. pylori strains were analyzed to assess the genotypes associated with MNZ resistance. We observed that the prevalences of rdxA sequences with missense, nonsense, and frameshift mutations were 70.25, 11.35, and 17.03%, respectively. Regarding the amino acid substitutions, T31E, H53R, D59N, L62V, S88P, G98S/N, R131K, and V172I were present in most strains regardless of the resistance phenotype. The correlation analysis showed R16H/C, Y47C, A67V/T, and V204I substitutions were associated with MNZ resistance. The mutation resulting in RdxA truncation was observed in 36.29% of the resistant strains, and 83.45% of these strains displayed high-level MNZ resistance (MIC > 256 μg/mL). Moreover, all strains with truncated mutation positions before amino acid 70 expressed high-level MNZ resistance. Our results indicated that most amino acid mutations probably contributed to the sequence diversity of RdxA, while R16H/C, Y47C, A67V/T, and V204I were potentially helpful to identify resistant strains. Although it was difficult to determine the mutations associated with MNZ resistance, the prediction of high-level resistance based on truncated characteristics of RdxA might be an important approach, which can effectively avoid H. pylori eradication therapy with unreasonable of MNZ dose increases for patients with high-level drug resistance. IMPORTANCE The increasing resistance to metronidazole impaired the efficacy of Helicobacter pylori eradication, and increasing the dose of metronidazole was recommended to overcome low-level resistance. For patients infected with highly resistant strains, the current empirical treatments, which generally used metronidazole in double doses or more, appeared impossibly to overcome the resistance and would only increase the incidence of adverse effects. Our results indicated that high-level metronidazole resistance was predominant, and almost half of the patients with high-level drug resistance could avoid usage of metronidazole based on the truncated mutations of RdxA sequences, which can effectively avoid H. pylori eradication therapy with unreasonable increases in the metronidazole dose." @default.
• W4328049268 created "2023-03-22" @default.
• W4328049268 creator A5017779885 @default.
• W4328049268 creator A5024180245 @default.
• W4328049268 creator A5024622671 @default.
• W4328049268 creator A5027746748 @default.
• W4328049268 creator A5028831855 @default.
• W4328049268 creator A5060860709 @default.
• W4328049268 creator A5070114596 @default.
• W4328049268 date "2023-04-13" @default.
• W4328049268 modified "2023-10-16" @default.
• W4328049268 title "RdxA Diversity and Mutations Associated with Metronidazole Resistance of <i>Helicobacter pylori</i>" @default.
• W4328049268 cites W1549404088 @default.
• W4328049268 cites W2001138478 @default.
• W4328049268 cites W2005522979 @default.
• W4328049268 cites W2015691327 @default.
• W4328049268 cites W2022020892 @default.
• W4328049268 cites W2026781921 @default.
• W4328049268 cites W2030038689 @default.
• W4328049268 cites W2044906864 @default.
• W4328049268 cites W2065265514 @default.
• W4328049268 cites W2068309369 @default.
• W4328049268 cites W2069378448 @default.
• W4328049268 cites W2086507424 @default.
• W4328049268 cites W2107878030 @default.
• W4328049268 cites W2110035469 @default.
• W4328049268 cites W2111942462 @default.
• W4328049268 cites W2112215083 @default.
• W4328049268 cites W2119429267 @default.
• W4328049268 cites W2123848597 @default.
• W4328049268 cites W2131112041 @default.
• W4328049268 cites W2143506604 @default.
• W4328049268 cites W2149770337 @default.
• W4328049268 cites W2167511982 @default.
• W4328049268 cites W2199203801 @default.
• W4328049268 cites W2320937221 @default.
• W4328049268 cites W2336356383 @default.
• W4328049268 cites W2336642788 @default.
• W4328049268 cites W2527848138 @default.
• W4328049268 cites W2766578585 @default.
• W4328049268 cites W2768903768 @default.
• W4328049268 cites W2790522681 @default.
• W4328049268 cites W2905232101 @default.
• W4328049268 cites W2908062341 @default.
• W4328049268 cites W2908980788 @default.
• W4328049268 cites W2991297139 @default.
• W4328049268 cites W3043156191 @default.
• W4328049268 cites W3134997483 @default.
• W4328049268 cites W3144709139 @default.
• W4328049268 doi "https://doi.org/10.1128/spectrum.03903-22" @default.
• W4328049268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36943041" @default.
• W4328049268 hasPublicationYear "2023" @default.
• W4328049268 type Work @default.
• W4328049268 citedByCount "3" @default.
• W4328049268 countsByYear W43280492682023 @default.
• W4328049268 crossrefType "journal-article" @default.
• W4328049268 hasAuthorship W4328049268A5017779885 @default.
• W4328049268 hasAuthorship W4328049268A5024180245 @default.
• W4328049268 hasAuthorship W4328049268A5024622671 @default.
• W4328049268 hasAuthorship W4328049268A5027746748 @default.
• W4328049268 hasAuthorship W4328049268A5028831855 @default.
• W4328049268 hasAuthorship W4328049268A5060860709 @default.
• W4328049268 hasAuthorship W4328049268A5070114596 @default.
• W4328049268 hasBestOaLocation W43280492681 @default.
• W4328049268 hasConcept C104317684 @default.
• W4328049268 hasConcept C127716648 @default.
• W4328049268 hasConcept C2776409635 @default.
• W4328049268 hasConcept C2777396551 @default.
• W4328049268 hasConcept C29906990 @default.
• W4328049268 hasConcept C501593827 @default.
• W4328049268 hasConcept C501734568 @default.
• W4328049268 hasConcept C523546767 @default.
• W4328049268 hasConcept C54355233 @default.
• W4328049268 hasConcept C75563809 @default.
• W4328049268 hasConcept C86803240 @default.
• W4328049268 hasConcept C89423630 @default.
• W4328049268 hasConcept C94665300 @default.
• W4328049268 hasConcept C96777560 @default.
• W4328049268 hasConceptScore W4328049268C104317684 @default.
• W4328049268 hasConceptScore W4328049268C127716648 @default.
• W4328049268 hasConceptScore W4328049268C2776409635 @default.
• W4328049268 hasConceptScore W4328049268C2777396551 @default.
• W4328049268 hasConceptScore W4328049268C29906990 @default.
• W4328049268 hasConceptScore W4328049268C501593827 @default.
• W4328049268 hasConceptScore W4328049268C501734568 @default.
• W4328049268 hasConceptScore W4328049268C523546767 @default.
• W4328049268 hasConceptScore W4328049268C54355233 @default.
• W4328049268 hasConceptScore W4328049268C75563809 @default.
• W4328049268 hasConceptScore W4328049268C86803240 @default.
• W4328049268 hasConceptScore W4328049268C89423630 @default.
• W4328049268 hasConceptScore W4328049268C94665300 @default.
• W4328049268 hasConceptScore W4328049268C96777560 @default.
• W4328049268 hasFunder F4320336343 @default.
• W4328049268 hasIssue "2" @default.
• W4328049268 hasLocation W43280492681 @default.
• W4328049268 hasLocation W43280492682 @default.
• W4328049268 hasLocation W43280492683 @default.
• W4328049268 hasOpenAccess W4328049268 @default.
• W4328049268 hasPrimaryLocation W43280492681 @default.
• W4328049268 hasRelatedWork W1540914548 @default.

• next